Bill117th CongressFiled Jun 17, 2021Commerce
H.Res. 484
Expressing the sense of the House of Representatives that the United States should not waive intellectual property rights relating to COVID-19 vaccines or treatments.
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Jun 17, 2021)
This resolution expresses the sense of the House of Representatives that the United States should not waive intellectual property protections for COVID-19 vaccines, treatments, or other related innovations.
What just happenedNov 1, 2022
Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
Who’s behind it
Rep. Miller-Meeks, Mariannette [R-IA-2](R-IA)Sponsor
23 cosponsors23 R
23cosponsors1committees4actions8subjects
- Introduced in HouseJun 17, 2021
- Nov 1, 2022Committee
Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
Courts, Intellectual Property, and the Internet Subcommittee - Jun 17, 2021IntroReferralH11100
Referred to the House Committee on the Judiciary.
Judiciary Committee - Jun 17, 2021IntroReferralIntro-H
Introduced in House
- Jun 17, 2021IntroReferral1000
Introduced in House